Omnicell (OMCL) Other Operating Expenses (2010 - 2022)

Omnicell (OMCL) posted quarterly Other Operating Expenses of -$3.5 million for Q1 2022, down 75.0% year-over-year from -$14.0 million in Q1 2021, and down 75.0% quarter-over-quarter from -$2.0 million in Q1 2021.

Omnicell (OMCL) Other Operating Expenses (2010 - 2022) Analysis & Trends

Omnicell (OMCL) has reported Other Operating Expenses for 4 consecutive years, with -$3.5 million the latest figure, recorded in Q1 2022.

  • In Q1 2022, Other Operating Expenses fell 75.0% year-over-year to -$3.5 million; the TTM figure through Dec 2022 stood at -$3.5 million (down 75.0% YoY), while the FY2015 annual figure was -$3.4 million, changed N/A from the prior year.
  • Other Operating Expenses eased to -$3.5 million in Q1 2022 per OMCL's latest filing, from -$2.0 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at -$2.0 million in Q1 2021 and bottomed at -$3.5 million in Q1 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Veeva Systems 39.72 Bn 32.40 Bn 662.02 Mn
2 BrightSpring Health Services 12.19 Bn 11.64 Bn 492.75 Mn
3 Healthequity 8.79 Bn 8.52 Bn 256.31 Mn
4 10x Genomics 7.31 Bn 6.76 Bn 112.50 Mn
5 Hinge Health 7.10 Bn 6.71 Bn 183.95 Mn
6 MiniMed 5.66 Bn 5.36 Bn 480.00 Mn
7 Waystar Holding 4.76 Bn 4.56 Bn 221.99 Mn
8 Doximity 4.46 Bn 3.77 Bn 132.93 Mn
9 Heartflow 3.66 Bn 3.28 Bn 53.19 Mn
10 Omnicell 1.70 Bn 1.41 Bn 152.94 Mn

Historic Data

Download Data
DateValue
Mar 31, 2022 -3.50 Mn
Mar 31, 2021 -2.00 Mn
Jun 30, 2015 -3.44 Mn
Sep 30, 2010 -43,000.00